Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 10/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | MLNR | O43193 | 1/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.64 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.64 |
| ▸ | HTR2A | P28223 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.64 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | HRH1 | P35367 | 1/20 | 0.64 |
| ▸ | DRD3 | P35462 | 1/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31693257 | 0.90 | ALOX5 (0.75) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL13953869 | 0.89 | ALOX5 (0.73) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL13953830 | 0.89 | ALOX5 (0.73) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL2857744 | 0.88 | KMT2A (0.70) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL2796202 | 0.88 | ALOX5 (0.60) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL28752891 | 0.88 | ALOX5 (0.58) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL27600510 | 0.87 | ALDH1A1 (0.57) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL13954020 | 0.86 | ALOX5 (0.69) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL13953832 | 0.86 | ALOX5 (0.69) | ALOX5MEN1KMT2AGAAMLNR | |
| SCHEMBL31693220 | 0.86 | ALOX5 (0.58) | ALOX5MEN1KMT2AGAAMLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| CN-119613209-A | Preparation method of modified nano silicon powder coated by polymer | 中国人民解放军空军工程大学 | 2025-03-14 | — | — | CN | claimed |
| CN-118724745-A | Asymmetric chiral gel factor for supermolecule assembly and preparation method and application thereof | 河南大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118668127-A | High-strength and high-purity cold stamping die steel and preparation method thereof | 宝武特种冶金有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-117586173-B | Preparation method of arbidol | 石家庄中硕制药有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-117586173-A | Preparation method of arbidol | 石家庄中硕制药有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117579003-A | High-precision instrument amplifier based on offset calibration of analog-digital hybrid architecture | 西安电子科技大学 | 2024-02-20 | — | — | CN | claimed |
| EP-4301742-A1 | TYPE-II PHOTOINITIATORS | ARKEMA FRANCE (FR) | 2024-01-10 | — | — | EP | claimed |
| CN-114507202-B | Phellinin compound and preparation method and application thereof | 海南大学 | 2023-10-03 | — | — | CN | claimed |
| CN-116466011-B | Detection method of arbidol hydrochloride related substances and application thereof | 则正(上海)生物科技有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-114507202-A | Morusin compound and preparation method and application thereof | 海南大学 | 2022-05-17 | — | — | CN | claimed |
| CN-111542637-B | High-strength austenite-based high-manganese steel material and manufacturing method thereof | 株式会社POSCO | 2022-05-10 | — | — | CN | claimed |
| CN-114397375-A | Method for detecting related substances of arbidol hydrochloride intermediate | 石家庄四药有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-111269168-B | Preparation method of arbidol intermediate | 苏州敬业医药化工有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-111533677-A | Method for synthesizing arbidol hydrochloride intermediate | 大连万福制药有限公司 | 2020-08-14 | — | — | CN | claimed |
| CN-111269168-A | Preparation method of arbidol intermediate | 苏州敬业医药化工有限公司 | 2020-06-12 | — | — | CN | claimed |
| CN-106083691-A | A kind of preparation method of arbidol HCl | 山东罗欣药业集团股份有限公司 | 2016-11-09 | — | — | CN | claimed |
| US-20090326037-A1 | Medicinal Agent For Treating Viral Infections | ZAKRYTOE AKTSIONERNOE OBSCHESTVO "MASTERKLONA" (RU) | 2009-12-31 | — | — | US | claimed |
| EP-1970061-A1 | MEDICINAL AGENT FOR TREATING VIRAL INFECTIONS | Zakrytoe Aktsionernoe Obschestvo "Masterklon" (RU) | 2008-09-17 | — | — | EP | claimed |
| US-5198552-A | Preparation by bromination, sulfiding, aminomethylation | NAUCHNO-ISSLEDOVATELSKY INSTITUT MEDITSINSKOI RADIOLOGII AKADEMII MEDITSINSKIKH NAUK SSSR (RU) | 1993-03-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326037-A1 | Medicinal Agent For Treating Viral Infections | ACE, HAVCR2, MME | ALOX5 1451/4885MEN1 2825/4885KMT2A 2362/4885 |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | DCLRE1A, CCR3, CCR8 | ALOX5 4247/4885MEN1 2393/4885KMT2A 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.